-
Loading metrics
Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study
- C. R. Kahlert,
- M. Cipriani,
- P. Vernazza
x
- Published: September 23, 2020
- https://doi.org/10.1371/journal.pone.0237770